Understanding how modern catalysts work in drug and chemical production
Mechanistic Investigation into Modern Catalytic Reactions
This study is exploring new ways to make medicines and important chemicals more efficiently using light and special proteins, which could lead to better drugs for patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of Ny,binghamton NIH-funded |
| Lab location | 1 site (Binghamton, United States) |
| Project ID | NIH-10912659 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind new catalytic methods that are crucial for creating pharmaceuticals and valuable chemicals. It focuses on two main areas: photoredox catalysis, which uses light to drive chemical reactions, and biocatalysis, which involves engineered enzymes. By studying the transition states of these reactions, the research aims to improve the efficiency and effectiveness of these catalytic processes, ultimately leading to better drug synthesis. Patients may benefit indirectly through the development of more effective medications resulting from these advancements.
Who could benefit from this research
Good fit: Patients who may benefit from this research are those with conditions that require innovative drug therapies developed through advanced catalytic processes.
Not a fit: Patients with conditions that do not rely on pharmaceutical interventions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more efficient and effective pharmaceuticals.
How similar studies have performed: Other research has shown success in understanding catalytic mechanisms, making this approach promising but still advancing in specific applications.
Where this research is happening
Binghamton, United States
- State University of Ny,binghamton — Binghamton, United States (Active)
Researchers
- Principal investigator: Hirschi, Jennifer — State University of Ny,binghamton
- Study coordinator: Hirschi, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.